Legend Biotech Corp
LEGN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001801198
In the last 90 days, Legend Biotech Corp insiders filed 0 open-market purchases and 2 sales; 219 institutions reported holding it in 13F filings for Q2 2026, worth $2.98B in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.
13F holders, Q3 2024
Institutional positions in Legend Biotech Corp as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 208
- +28 vs. Q2 2024
- Shares held
- 91.1M
- +5.27M (+6.1%) vs. Q2 2024
- Total value
- $4.44B
- +$637.9M (+16.8%) vs. Q2 2024
- New holders
- 44
- 70 more added
- Sold out
- 16
- 70 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LEGN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 219 | $2.98B |
| Q1 2026 | 190 | $1.74B |
| Q4 2025 | 200 | $1.90B |
| Q3 2025 | 200 | $2.73B |
| Q2 2025 | 211 | $3.00B |
| Q1 2025 | 208 | $2.91B |
| Q4 2024 | 211 | $3.23B |
| Q3 2024 | 208 | $4.44B |
| Q2 2024 | 181 | $4.06B |
| Q1 2024 | 192 | $4.85B |
| Q4 2023 | 206 | $5.16B |
| Q3 2023 | 200 | $5.78B |
| Q2 2023 | 194 | $5.81B |
| Q1 2023 | 160 | $3.28B |
| Q4 2022 | 170 | $3.18B |
| Q3 2022 | 159 | $2.60B |
| Q2 2022 | 151 | $2.90B |
| Q1 2022 | 141 | $1.85B |
| Q4 2021 | 139 | $2.34B |
| Q3 2021 | 88 | $1.97B |
| Q2 2021 | 86 | $1.16B |
| Q1 2021 | 71 | $765.9M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Legend Biotech Corp; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Farther Finance Advisors, LLC | 75 | $3.65K | 0.00% | +18+31.6% | Added |
| GPS Wealth Strategies Group, LLC | 45 | $2.19K | 0.00% | 00.0% | Unchanged |
| Macroview Investment Management LLC | 36 | $1.75K | 0.00% | 00.0% | Unchanged |
| J.Safra Asset Management Corp | 28 | $1.38K | 0.00% | +28 | New |
| Smartleaf Asset Management LLC | 21 | $1.03K | 0.00% | +21 | New |
| Raffa Wealth Management, LLC | 16 | $780 | 0.00% | 00.0% | Unchanged |
| Abound Wealth Management | 4 | $195 | 0.00% | 00.0% | Unchanged |
| Lazard Asset Management LLC | 9 | $0 | 0.00% | −16−64.0% | Reduced |
| Paradigm Biocapital Advisors LP | 0 | $0 | 0.00% | −1,203,308−100.0% | Sold out |
| Avidity Partners Management LP | 0 | $0 | 0.00% | −398,000−100.0% | Sold out |
| Magnetar Financial LLC | 0 | $0 | 0.00% | −251,667−100.0% | Sold out |
| Ally Bridge Group (NY) LLC | 0 | $0 | 0.00% | −195,000−100.0% | Sold out |
| Senator Investment Group LP | 0 | $0 | 0.00% | −155,000−100.0% | Sold out |
| Hudson Bay Capital Management LP | 0 | $0 | 0.00% | −55,000−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −29,905−100.0% | Sold out |
| Old Well Partners, LLC | 0 | $0 | 0.00% | −29,301−100.0% | Sold out |
| Parkwood LLC | 0 | $0 | 0.00% | −13,250−100.0% | Sold out |
| Alyeska Investment Group, L.P. | 0 | $0 | 0.00% | −10,513−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −6,151−100.0% | Sold out |
| Chicago Partners Investment Group LLC | 0 | $0 | 0.00% | −4,762−100.0% | Sold out |
| Bayesian Capital Management, LP | 0 | $0 | 0.00% | −5,741−100.0% | Sold out |
| EntryPoint Capital, LLC | 0 | $0 | 0.00% | −2,850−100.0% | Sold out |
| AM Squared Ltd | 0 | $0 | 0.00% | −1,600−100.0% | Sold out |
| Vermillion & White Wealth Management Group, LLC | 0 | $0 | 0.00% | −25−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |